Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Multiple Sclerosis

  Free Subscription


1 Acta Neurol Scand
1 Acta Neuropathol
1 Arch Phys Med Rehabil
1 Bone Marrow Transplant
1 Brain
1 Eur Neurol
1 J Neurol
6 J Neurol Sci
1 Lancet Neurol
2 Mult Scler
1 Neurologia
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Neurol Scand

  1. ELKJAER ML, Molnar T, Illes Z
    Teriflunomide for multiple sclerosis in real-world setting.
    Acta Neurol Scand. 2017 Mar 20. doi: 10.1111/ane.12755.
    PubMed     Text format     Abstract available

    Acta Neuropathol

  2. VAN DEN BERG R, Hoogenraad CC, Hintzen RQ
    Axonal transport deficits in multiple sclerosis: spiraling into the abyss.
    Acta Neuropathol. 2017 Mar 18. doi: 10.1007/s00401-017-1697.
    PubMed     Text format     Abstract available

    Arch Phys Med Rehabil

  3. KOZLOWSKI AJ, Fabian M, Lad D, Delgado A, et al
    Feasibility and safety of a powered exoskeleton for assisted walking for persons with multiple sclerosis: a single-group preliminary study.
    Arch Phys Med Rehabil. 2017 Mar 15. pii: S0003-9993(17)30144.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  4. BURMAN J, Kirgizov K, Carlson K, Badoglio M, et al
    Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transp
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  5. LONGONI G, Brown RA, MomayyezSiahkal P, Elliott C, et al
    White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Brain. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available

    Eur Neurol

  6. BURGGRAAFF J, Knol DL, Uitdehaag BM
    Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Eur Neurol. 2017;77.
    PubMed     Text format     Abstract available

    J Neurol

  7. PREZIOSA P, Martinelli V, Ferre L, Guaschino C, et al
    Moyamoya disease mimicking the first attack of multiple sclerosis.
    J Neurol. 2017 Mar 17. doi: 10.1007/s00415-017-8458.
    PubMed     Text format    

    J Neurol Sci

  8. RUBEGNI A, Battisti C, Tessa A, Cerase A, et al
    SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing.
    J Neurol Sci. 2017;375:198-202.
    PubMed     Text format     Abstract available

  9. NOORI-ZADEH A, Mesbah-Namin SA, Saboor-Yaraghi AA
    Epigenetic and gene expression alterations of FOXP3 in the T cells of EAE mouse model of multiple sclerosis.
    J Neurol Sci. 2017;375:203-208.
    PubMed     Text format     Abstract available

  10. REEN GK, Silber E, Langdon DW
    Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review.
    J Neurol Sci. 2017;375:107-122.
    PubMed     Text format     Abstract available

  11. BOURNE T, Waltz M, Casper TC, Kavak K, et al
    Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population.
    J Neurol Sci. 2017;375:371-375.
    PubMed     Text format     Abstract available

  12. LYSANDROPOULOS AP, Mavroudakis N, Pandolfo M, El Hafsi K, et al
    HLA genotype as a marker of multiple sclerosis prognosis: A pilot study.
    J Neurol Sci. 2017;375:348-354.
    PubMed     Text format     Abstract available

  13. HARTL C, Obermeier V, Gerdes LA, Brugel M, et al
    Seasonal variations of 25-OH vitamin D serum levels are associated with clinical disease activity in multiple sclerosis patients.
    J Neurol Sci. 2017;375:160-164.
    PubMed     Text format     Abstract available

    Lancet Neurol

  14. HOHLFELD R, Meinl E
    Ocrelizumab in multiple sclerosis: markers and mechanisms.
    Lancet Neurol. 2017;16:259-261.
    PubMed     Text format    

    Mult Scler

  15. FEINSTEIN A, Pavisian B
    Multiple sclerosis and suicide.
    Mult Scler. 2017 Mar 1:1352458517702553. doi: 10.1177/1352458517702553.
    PubMed     Text format     Abstract available

  16. CHARVET LE, Shaw M, Frontario A, Langdon D, et al
    Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.
    Mult Scler. 2017 Mar 1:1352458517701588. doi: 10.1177/1352458517701588.
    PubMed     Text format     Abstract available


  17. GONZALEZ GOMEZ A, Garcia-Ben A, Soler Garcia A, Garcia-Basterra I, et al
    Longitudinal study of visual function in patients with relapsing-remitting multiple sclerosis with and without a history of optic neuritis.
    Neurologia. 2017 Mar 15. pii: S0213-4853(17)30024.
    PubMed     Text format     Abstract available

    PLoS One

  18. HEGEN H, Auer M, Bsteh G, Di Pauli F, et al
    Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.
    PLoS One. 2017;12:e0174005.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.